OLBA HEALTHCARE HOLDINGS, Inc. (TSE:2689) Stock Goes Ex-Dividend In Just Three Days

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that OLBA HEALTHCARE HOLDINGS, Inc. (TSE:2689) is about to go ex-dividend in just 3 days. The ex-dividend date is usually set to be two business days before the record date, which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important as the process of settlement involves at least two full business days. So if you miss that date, you would not show up on the company's books on the record date. Thus, you can purchase OLBA HEALTHCARE HOLDINGS' shares before the 27th of June in order to receive the dividend, which the company will pay on the 29th of September.

The company's next dividend payment will be JP¥80.00 per share. Last year, in total, the company distributed JP¥80.00 to shareholders. Based on the last year's worth of payments, OLBA HEALTHCARE HOLDINGS has a trailing yield of 3.8% on the current stock price of JP¥2123.00. If you buy this business for its dividend, you should have an idea of whether OLBA HEALTHCARE HOLDINGS's dividend is reliable and sustainable. As a result, readers should always check whether OLBA HEALTHCARE HOLDINGS has been able to grow its dividends, or if the dividend might be cut.

Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. That's why it's good to see OLBA HEALTHCARE HOLDINGS paying out a modest 36% of its earnings. A useful secondary check can be to evaluate whether OLBA HEALTHCARE HOLDINGS generated enough free cash flow to afford its dividend. Over the past year it paid out 138% of its free cash flow as dividends, which is uncomfortably high. We're curious about why the company paid out more cash than it generated last year, since this can be one of the early signs that a dividend may be unsustainable.

While OLBA HEALTHCARE HOLDINGS's dividends were covered by the company's reported profits, cash is somewhat more important, so it's not great to see that the company didn't generate enough cash to pay its dividend. Cash is king, as they say, and were OLBA HEALTHCARE HOLDINGS to repeatedly pay dividends that aren't well covered by cashflow, we would consider this a warning sign.

See our latest analysis for OLBA HEALTHCARE HOLDINGS

Click here to see how much of its profit OLBA HEALTHCARE HOLDINGS paid out over the last 12 months.

historic-dividend
TSE:2689 Historic Dividend June 23rd 2025
Advertisement

Have Earnings And Dividends Been Growing?

Businesses with strong growth prospects usually make the best dividend payers, because it's easier to grow dividends when earnings per share are improving. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. With that in mind, we're encouraged by the steady growth at OLBA HEALTHCARE HOLDINGS, with earnings per share up 10.0% on average over the last five years. Earnings have been growing at a steady rate, but we're concerned dividend payments consumed most of the company's cash flow over the past year.

Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. In the past 10 years, OLBA HEALTHCARE HOLDINGS has increased its dividend at approximately 10% a year on average. We're glad to see dividends rising alongside earnings over a number of years, which may be a sign the company intends to share the growth with shareholders.

The Bottom Line

Is OLBA HEALTHCARE HOLDINGS worth buying for its dividend? OLBA HEALTHCARE HOLDINGS has seen its earnings per share grow steadily and paid out less than half its profit over the last year. Unfortunately, its dividend was not well covered by free cash flow. Overall we're not hugely bearish on the stock, but there are likely better dividend investments out there.

So if you want to do more digging on OLBA HEALTHCARE HOLDINGS, you'll find it worthwhile knowing the risks that this stock faces. For example - OLBA HEALTHCARE HOLDINGS has 2 warning signs we think you should be aware of.

If you're in the market for strong dividend payers, we recommend checking our selection of top dividend stocks.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:2689

OLBA HEALTHCARE HOLDINGS

Operates as a distributor of medical equipment and pharmaceuticals in Japan.

Flawless balance sheet established dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
GIFT logo
Lou_Basenese on Giftify ·

Giftify ($GIFT): A Small-Cap Incentives Platform with More ScaleThan Its Valuation Suggests

Fair Value:US$2.550.4% undervalued
7 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$58016.3% overvalued
23 users have followed this narrative
2 users have commented on this narrative
21 users have liked this narrative
TH
LMT logo
TheBestInvestor on Lockheed Martin ·

Orbit + Aero + Defense

Fair Value:US$673.8817.6% undervalued
13 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AG
Agricola
STGO logo
Agricola on Steppe Gold ·

A case for Steppe Gold, bear case CAD $4, base case CAD $15, bull case CAD $25

Fair Value:CA$2594.1% undervalued
19 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative

Updated Narratives

IN
investoid
SFTB.Y logo
investoid on SoftBank Group ·

SoftBank Group projected for a 47.93% profit margin surge with 8.04x future P/E

Fair Value:US$122.5885.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
BrandonM84
LWLG logo
BrandonM84 on Lightwave Logic ·

Pre Commercialization optimism

Fair Value:US$14.54.6% overvalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FA
ASM logo
FA_Trader on ASM Automation Group Berhad ·

ASM Automation: A focused automation player with improving earnings traction and a clearer growth platform

Fair Value:RM 0.2740.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3959.6% overvalued
52 users have followed this narrative
3 users have commented on this narrative
43 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.233.7% undervalued
64 users have followed this narrative
1 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$579.5725.3% undervalued
1381 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative